Epstein-Barr Virus Infection Alters Cellular Signal Cascades in Human Nasopharyngeal Epithelial Cells 1

Epstein-Barr virus (EBV) latent infection is a critical event in nasopharyngeal carcinoma (NPC) tumorigenesis. EBV-encoded genes have been shown to be involved in immune evasion and in the regulation of various cellular signaling cascades. To elucidate the roles of EBV in NPC development, stable infection of EBV in nasopharyngeal epithelial cell lines was established. Similar to primary tumors of NPC, these infected cells exhibited a type II EBV latency expression pattern. In this study, multiple cellular signaling pathways in EBV-infected cells were investigated. We first demonstrated that in vitro EBV infection resulted in the activation of STAT3 and NF K B signal cascades in nasopharyngeal epithelial cells. Increased expression of their downstream targets (c-Myc, Bcl-xL, IL-6, LIF, SOCS-1, SOCS-3, VEGF, and COX-2) was also observed. Moreover, EBV latent infection induced the suppression of p38-MAPK activities, but did not activate PKR cas-cade. Our findings suggest that EBV latent infection is able to manipulate multiple cellular signal cascades to protect infected cells from immunologic attack and to facilitate cancer development. Neoplasia (2006) 8, 173–180

[1]  R. Chang,et al.  Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress , 2005, Molecular carcinogenesis.

[2]  C. Geisler,et al.  Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNα , 2005, Leukemia.

[3]  O. Silvennoinen,et al.  STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. , 2004, Cytokine & growth factor reviews.

[4]  T. Portis,et al.  Epstein–Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway , 2004, Oncogene.

[5]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[6]  K. Kiguchi,et al.  Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. , 2004, The Journal of clinical investigation.

[7]  S. Tsao,et al.  Phenotypic alterations induced by the Hong Kong‐prevalent Epstein‐Barr virus‐encoded LMP1 variant (2117‐LMP1) in nasopharyngeal epithelial cells , 2004, International journal of cancer.

[8]  Kwok Wai Lo,et al.  Focus on nasopharyngeal carcinoma. , 2004, Cancer cell.

[9]  Hua Yu,et al.  Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.

[10]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[11]  A. Shiau,et al.  Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis , 2003, British Journal of Cancer.

[12]  Y. Wong,et al.  Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1 , 2003, Laboratory Investigation.

[13]  L. Hutt-Fletcher,et al.  A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus , 2003, Journal of Virology.

[14]  E. Fikrig,et al.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Tsao,et al.  Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. , 2002, Biochimica et biophysica acta.

[16]  L. Ellis,et al.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis , 2002, Oncogene.

[17]  A. Nanbo,et al.  Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. , 2002, The EMBO journal.

[18]  S. Maruo,et al.  Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. , 2001, The Journal of general virology.

[19]  T. Yoshizaki,et al.  Induction of cyclooxygenase-2 by Epstein–Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Tokeshi,et al.  The Relationship Between Microvessel Density, the Expression of Vascular Endothelial Growth Factor (VEGF), and the Extension of Nasopharyngeal Carcinoma , 2000, The Laryngoscope.

[21]  K. M. Bendt,et al.  Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt , 2000, Journal of Virology.

[22]  G. Tse,et al.  High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. , 2000, Cancer research.

[23]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[24]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[25]  Ching‐Hwa Tsai,et al.  Requirement for Cell-to-Cell Contact in Epstein-Barr Virus Infection of Nasopharyngeal Carcinoma Cells and Keratinocytes , 1999, Journal of Virology.

[26]  S. Cheung,et al.  Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virus , 1999, International journal of cancer.

[27]  K. Takada,et al.  Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells , 1998, Journal of Virology.

[28]  W. Chen,et al.  Characterization of seven newly established nasopharyngeal carcinoma cell lines. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[29]  Y. F. Poon,et al.  Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx , 1980, International journal of cancer.